bioAffinity Technologies, Inc. — Director's Dealing 2023

Jul 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2023-01-01

Reporting Person: GIRGENTI STEVEN (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-01	Common Stock	A	8227	$2.28	Acquired	869326	Direct
2023-04-15	Common Stock	A	9920	$1.89	Acquired	879246	Direct
2023-07-01	Common Stock	A	10245	$1.83	Acquired	889491	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8955	Indirect

Footnotes

F1: Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Girgenti of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.

F2: Represents a grant from the Issuer to Mr. Girgenti of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Girgenti continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.

F3: Represents a grant from the Issuer to Mr. Girgenti of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.

F4: Represents shares of Common Stock owned directly by the Cranye Girgenti Testamentary Trust (the "Trust") and indirectly by Mr. Girgenti, as co-trustee of the Trust, as previously reported on a Form 4 filed by Mr. Girgenti on November 8, 2022. Mr. Girgenti disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Such total number of shares of Common Stock owned by the Trust, and by Mr. Girgenti indirectly.